BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22273698)

  • 1. IL-6 stimulates STAT3 and Pim-1 kinase in pancreatic cancer cell lines.
    Block KM; Hanke NT; Maine EA; Baker AF
    Pancreas; 2012 Jul; 41(5):773-81. PubMed ID: 22273698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIM kinase inhibitors downregulate STAT3(Tyr705) phosphorylation.
    Chang M; Kanwar N; Feng E; Siu A; Liu X; Ma D; Jongstra J
    Mol Cancer Ther; 2010 Sep; 9(9):2478-87. PubMed ID: 20667852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropilin-1 (NRP-1) upregulated by IL-6/STAT3 signaling contributes to invasion in pancreatic neuroendocrine neoplasms.
    Yang Y; Yang L; Li Y
    Hum Pathol; 2018 Nov; 81():192-200. PubMed ID: 30420046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitro.
    Huang C; Yang G; Jiang T; Zhu G; Li H; Qiu Z
    Neoplasma; 2011; 58(5):396-405. PubMed ID: 21744993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minocycline suppresses interleukine-6, its receptor system and signaling pathways and impairs migration, invasion and adhesion capacity of ovarian cancer cells: in vitro and in vivo studies.
    Ataie-Kachoie P; Morris DL; Pourgholami MH
    PLoS One; 2013; 8(4):e60817. PubMed ID: 23593315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of IL-6 and AG490 on regulation of Stat3 signaling pathway and invasion of human pancreatic cancer cells in vitro.
    Huang C; Yang G; Jiang T; Huang K; Cao J; Qiu Z
    J Exp Clin Cancer Res; 2010 May; 29(1):51. PubMed ID: 20482858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZIP4 regulates pancreatic cancer cell growth by activating IL-6/STAT3 pathway through zinc finger transcription factor CREB.
    Zhang Y; Bharadwaj U; Logsdon CD; Chen C; Yao Q; Li M
    Clin Cancer Res; 2010 Mar; 16(5):1423-30. PubMed ID: 20160059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
    Lee TL; Yeh J; Van Waes C; Chen Z
    Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of ERK and Mutual Regulation of Stat3 and SP1 Contribute to Inhibition of PDK1 Expression by Atractylenolide-1 in Human Lung Cancer Cells.
    Xiao Q; Zheng F; Wu J; Tang Q; Wang W; Hann SS
    Cell Physiol Biochem; 2017; 43(6):2353-2366. PubMed ID: 29073620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cucurbitacin I induces pro-death autophagy in A549 cells via the ERK-mTOR-STAT3 signaling pathway.
    Ni Y; Wu S; Wang X; Zhu G; Chen X; Ding Y; Jiang W
    J Cell Biochem; 2018 Jul; 119(7):6104-6112. PubMed ID: 29575175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a phenanthrene derivative as a potent anticancer drug with Pim kinase inhibitory activity.
    Wang YY; Taniguchi T; Baba T; Li YY; Ishibashi H; Mukaida N
    Cancer Sci; 2012 Jan; 103(1):107-15. PubMed ID: 21981263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT3/Pim-1 signaling pathway plays a crucial role in endothelial differentiation of cardiac resident Sca-1+ cells both in vitro and in vivo.
    Iwakura T; Mohri T; Hamatani T; Obana M; Yamashita T; Maeda M; Katakami N; Kaneto H; Oka T; Komuro I; Azuma J; Nakayama H; Fujio Y
    J Mol Cell Cardiol; 2011 Aug; 51(2):207-14. PubMed ID: 21600215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor synergy of interleukin-6 (IL-6) and insulin-like growth factor-I in myeloma cells that highly express IL-6 receptor alpha [corrected].
    Abroun S; Ishikawa H; Tsuyama N; Liu S; Li FJ; Otsuyama K; Zheng X; Obata M; Kawano MM
    Blood; 2004 Mar; 103(6):2291-8. PubMed ID: 14592826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
    Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 induces proliferation in adult spinal cord-derived neural progenitors via the JAK2/STAT3 pathway with EGF-induced MAPK phosphorylation.
    Kang MK; Kang SK
    Cell Prolif; 2008 Jun; 41(3):377-92. PubMed ID: 18485152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of pancreatic cancer cell growth by cucurbitacin B through modulation of signal transducer and activator of transcription 3 signaling.
    Zhang M; Sun C; Shan X; Yang X; Li-Ling J; Deng Y
    Pancreas; 2010 Aug; 39(6):923-9. PubMed ID: 20182390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of activated pSTAT3 and PIM-1 in the pulmonary vasculature of experimental congenital diaphragmatic hernia.
    Hofmann AD; Takahashi T; Duess J; Gosemann JH; Puri P
    J Pediatr Surg; 2015 Jun; 50(6):908-11. PubMed ID: 25812446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma.
    Miao JW; Liu LJ; Huang J
    Int J Oncol; 2014 Jul; 45(1):165-76. PubMed ID: 24806843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB.
    Melisi D; Niu J; Chang Z; Xia Q; Peng B; Ishiyama S; Evans DB; Chiao PJ
    Mol Cancer Res; 2009 May; 7(5):624-33. PubMed ID: 19435817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reduction of IL-6 gene expression, pAKT, pERK1/2, pSTAT3 signaling pathways and invasion activity by gallic acid in prostate cancer PC3 cells.
    Heidarian E; Keloushadi M; Ghatreh-Samani K; Valipour P
    Biomed Pharmacother; 2016 Dec; 84():264-269. PubMed ID: 27665471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.